NLRP3 and type 2 diabetes mellitus: In T2D, chronic low-grade inflammation sustained by NLRP3 activation exacerbates insulin resistance in peripheral tissues and decreases β-cell mass via IL-1β-mediated apoptosis and pyroptosis [104].